Valued at $310.0M at its later-stage round, Jan 2025. Nothing has traded since.
- ·The complete investor list: 37 names
- ·Watch Ashvattha Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Ashvattha Therapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2021 | Later Stage VC | $60.2M | ▮ | ▮ |
| May 2019 | Seed Round | $250K | ▮ | ▮ |
| May 2018 | Seed Round | $400K | ▮ | ▮ |
| Feb 2016 | Seed Round | $300K | ▮ | ▮ |
Membership and data by Private Market View
Ashvattha Therapeutics valuation
Ashvattha Therapeutics was valued at $310 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Ashvattha Therapeutics raised?
Ashvattha Therapeutics has raised $217 million in total; 4 of its rounds are on record, from 2016 on. The largest on record was a $60.2 million later-stage round in Apr 2021.
Ashvattha Therapeutics has filed 7 Form Ds with the SEC since 2016, most recently in Dec 2022 ($60.2 million sold to 107 investors).
How Ashvattha Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ashvattha Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Ashvattha Therapeutics
- What is Ashvattha Therapeutics worth?
- Ashvattha Therapeutics is valued at $310.0M as of Oct 2026. Valued at $310.0M at its later-stage round, Jan 2025. Nothing has traded since.
- How much has Ashvattha Therapeutics raised?
- Ashvattha Therapeutics has raised $217.2M in total funding across 4 recorded rounds.
- When did Ashvattha Therapeutics last raise?
- Ashvattha Therapeutics last raised in Apr 2021 (Later Stage VC), raising $60.2M.